Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Hls Therapeutics Inc (HLS.TO)

Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
HLS Therapeutics to Host Q1 Fiscal 2024 Financial Results Conference Call Newswire.ca - Thu Apr 25, 7:50AM CDT

/CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), announces that it will release its Q1 fiscal 2024 financial results on Thursday, May 9, 2024....

HLS.TO : 4.65 (unch)
Stocks in play: HLS Therapeutics Inc. Baystreet - Tue Apr 9, 9:08AM CDT

Announces that Chief Executive Officer Craig Millian will present at the Bloom Burton & Co. Healthcare ...

HLS.TO : 4.65 (unch)
HLS Therapeutics to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference Newswire.ca - Tue Apr 9, 5:30AM CDT

/CNW/ - HLS Therapeutics Inc. (HLS or the Company) (TSX: HLS), a pharmaceutical company focusing on addressing unmet needs in the treatment of psychiatric...

HLS.TO : 4.65 (unch)
New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups Newswire.ca - Mon Apr 8, 5:30AM CDT

/CNW/ - HLS Therapeutics Inc. (HLS or the Company) (TSX: HLS), a pharmaceutical company focusing on addressing unmet needs in the treatment of psychiatric...

AMRN : 0.9180 (+9.38%)
HLS.TO : 4.65 (unch)
HLS Therapeutics Announces Fiscal 2023 Financial Results Newswire.ca - Thu Mar 14, 5:30AM CDT

/CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focused on addressing unmet needs in the treatment of psychiatric...

PFE : 27.70 (+1.91%)
HLS.TO : 4.65 (unch)
HLS Therapeutics to Host Q4 and Fiscal 2023 Financial Results Conference Call Newswire.ca - Thu Feb 29, 5:30AM CST

/CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), announces that it will release its Q4 and fiscal 2023 financial results on Thursday, March...

HLS.TO : 4.65 (unch)
HLS Announces that Vascepa® is now reimbursed by British Columbia's Provincial Drug Plan Newswire.ca - Tue Feb 6, 5:30AM CST

/CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focusing on addressing unmet needs in the treatment of psychiatric...

HLS.TO : 4.65 (unch)
HLS Therapeutics Announces CFO Departure Newswire.ca - Mon Dec 18, 2023

/CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focused on addressing unmet needs in the treatment of psychiatric...

VCM.TO : 19.80 (-0.50%)
HLS.TO : 4.65 (unch)
New REDUCE-IT® Analyses Show Vascepa® (Icosapent Ethyl) Associated with 29 Percent Relative Risk Reduction Compared with Placebo in Prespecified Subgroup of Patients with Metabolic Syndrome, but Without Diabetes at Baseline Newswire.ca - Tue Nov 14, 2023

/CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focused on addressing unmet needs in the treatment of psychiatric...

HLS.TO : 4.65 (unch)
HLS Therapeutics Announces Q3 Fiscal 2023 Financial Results and Renewal of Normal Course Issuer Bid Newswire.ca - Thu Nov 9, 2023

/CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focused on addressing unmet needs in the treatment of psychiatric...

PFE : 27.70 (+1.91%)
HLS.TO : 4.65 (unch)

Barchart Exclusives

Nasdaq Futures Climb on Upbeat Apple Results, U.S. Jobs Report in Focus Barchart - 20 minutes ago
June Nasdaq 100 E-Mini futures (NQM24) are trending up +0.56% this morning as market participants cheered forecast-beating quarterly results and a record share buyback from tech giant Apple and looked ahead to critical U.S. non-farm payroll data due later in the day. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot